Understanding OR10AC1 Variant 1: A Potential Drug Target (G392133)

Understanding OR10AC1 Variant 1: A Potential Drug Target

OR10AC1 (OR10AC1 variant 1) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and lungs. It is a member of the OR10 subfamily of the superfamily of cytoskeletal proteins known as the A-type cytoskeleton. OR10AC1 is involved in the regulation of cell shape, and has been implicated in a number of cellular processes, including cell division, migration, and cytoskeletal organization.

In recent years, researchers have been interested in studying the biology of OR10AC1, and have identified several potential drug targets that can be targeted with small molecules. One of these drug targets is the OR10AC1 variant 1 protein, which is a unique variant of OR10AC1 that is characterized by a single amino acid substitution at position 109.

The OR10AC1 variant 1 protein is expressed in various tissues throughout the body, including the brain, heart, and lungs, and is involved in the regulation of cell shape and the formation of the cytoskeleton. It is a member of the OR10 subfamily of the A -type cytoskeleton, and is composed of a unique sequence of 21 amino acids.

Research has shown that OR10AC1 variant 1 is involved in a number of cellular processes, including cell division, migration, and cytoskeletal organization. It is expressed in the brain, where it is involved in the regulation of neuronal excitability and synaptic plasticity, and in the heart, where it is involved in the regulation of cardiac contractility and myocardial fibrosis.

Despite its involvement in several important cellular processes, the OR10AC1 variant 1 protein is not well understood, and there are few research studies that have focused on its biology. However, the OR10AC1 variant 1 protein is a potential drug target, due to its unique structure and its involvement in several important cellular processes.

One of the challenges in studying OR10AC1 variant 1 is its high level of expression, as it is constantly produced in the body. However, researchers have been able to use several techniques to study its biology, including mass spectrometry, affinity purification, and in vitro assays.

One of the promising aspects of OR10AC1 variant 1 is its potential as a drug target. Studies have shown that the OR10AC1 variant 1 protein is involved in several important cellular processes, including cell division, migration, and cytoskeletal organization. It is also expressed in several tissues throughout the body, which suggests that it could be a useful target for small molecules.

In addition, the OR10AC1 variant 1 protein is a unique variant of OR10AC1, which makes it a promising target for drug development. Studies have shown that the OR10AC1 variant 1 protein is able to inhibit the activity of several known drug targets, including tyrosine kinase and voltage-gated ion channels. This suggests that it could be a useful target for small molecules that are able to inhibit the activity of these drug targets.

In conclusion, OR10AC1 variant 1 is a protein that is expressed in various tissues throughout the body, and is involved in the regulation of cell shape and the formation of the cytoskeleton. It is a member of the OR10 subfamily of the A-type cytoskeleton, and is composed of a unique sequence of 21 amino acids. Studies have shown that OR10AC1 variant 1 is involved in several important cellular processes, including cell division, migration, and cytoskeletal organization. It is also a potential drug target, due to its unique structure and its involvement in several important cellular processes. Further research is needed to fully understand the biology of OR10AC1 variant 1, and to develop small molecules that can interact with it.

Protein Name: Olfactory Receptor Family 10 Subfamily AC Member 1 (gene/pseudogene)

Functions: Odorant receptor

The "OR10AC1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR10AC1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR10AD1 | OR10AF1P | OR10AG1 | OR10AK1P | OR10C1 | OR10D1P | OR10D3 | OR10D4P | OR10G2 | OR10G3 | OR10G4 | OR10G7 | OR10G8 | OR10G9 | OR10H1 | OR10H2 | OR10H3 | OR10H4 | OR10H5 | OR10J1 | OR10J2P | OR10J3 | OR10J5 | OR10K1 | OR10K2 | OR10P1 | OR10Q1 | OR10R2 | OR10S1 | OR10T2 | OR10V1 | OR10W1 | OR10X1 | OR10Z1 | OR11A1 | OR11G2 | OR11H1 | OR11H12 | OR11H13P | OR11H2 | OR11H5P | OR11H6 | OR11H7 | OR11J2P | OR11J5P | OR11K2P | OR11L1 | OR11M1P | OR12D2 | OR12D3 | OR13A1 | OR13C2 | OR13C3 | OR13C4 | OR13C5 | OR13C8 | OR13C9 | OR13D1 | OR13F1 | OR13G1 | OR13H1 | OR13J1 | OR13Z2P | OR14A16 | OR14A2 | OR14C36 | OR14I1 | OR14J1 | OR14L1P | OR1A1 | OR1A2 | OR1B1 | OR1C1 | OR1D2 | OR1D4 | OR1D5 | OR1E1 | OR1E2 | OR1E3 | OR1F1 | OR1F2P | OR1G1 | OR1I1 | OR1J1 | OR1J2 | OR1J4 | OR1K1 | OR1L1 | OR1L3 | OR1L4 | OR1L6 | OR1L8 | OR1M1 | OR1N1 | OR1N2 | OR1P1 | OR1Q1 | OR1S1 | OR1S2 | OR2A1